Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What if...

The key phrase is "TPL granted" not Patriot. So. what was granted? Perhaps the right to commerialize the MMP which we own 50% of. According to our agreement with TPL :

The TPL Group (Cupertino, Calif.) has been granted full responsibility and authority for the commercialization and licensing of a unified portfolio of ten patents. This ends years of litigation between Patriot Scientific (San Diego, Calif.) and The TPL Group over title to certain patents, Patriot Scientific said Tuesday (June 7).

So, is this right transferable? The term"Business Agreement" in the PR would indicate the possibility of the above conjecture.

Now does this qualify as a material event. If so then a 8K should be forth-comming.

Share
New Message
Please login to post a reply